<p>A new paper in JAMA describes how, despite widespread enthusiasm about artificial intelligence's potential to revolutionize healthcare and the use of AI-powered tools on millions of patients already, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients. </p>
This Medical News article is an interview with John Ayers, PhD, MA, vice chief of innovation in the Division of Infectious Diseases & Global Public Health a